Dr. Steven Hatfill, a former adviser to the Trump administration’s trade chief, says a “pretty good plan” is in the works by a "government in waiting" to counter what many experts see as a failed pandemic response. This strategy begins with repurposed drugs.

“There's roughly about over 1,400 agents that cause human disease,” Dr. Hatfill said on Frontline Health. “Only about I would say 27 viral families have viruses that are … life-threatening."

"Let's look at these 20,000 drugs against 27 viral families. That's something we could start tomorrow.”

In 2020, the Trump administration took steps in this direction by procuring a significant quantity of hydroxychloroquine for early outpatient treatment against the SARS-COV-2 virus.
“We [had] 62 million doses in the national stockpile,” said Dr. Hatfill.

But according to him, that caught the soon to be, Biden-appointed, FDA commissioner by surprise.

Read Full Article Here